Literature DB >> 27345427

Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease.

Romuald Girard1, Hussein A Zeineddine1, Courtney Orsbon2, Huan Tan1, Thomas Moore1, Nick Hobson1, Robert Shenkar1, Rhonda Lightle1, Changbin Shi1, Maged D Fam1, Ying Cao1, Le Shen3, April I Neander2, Autumn Rorrer4, Carol Gallione4, Alan T Tang5, Mark L Kahn5, Douglas A Marchuk4, Zhe-Xi Luo2, Issam A Awad6.   

Abstract

BACKGROUND: Cerebral cavernous malformations (CCMs) are hemorrhagic brain lesions, where murine models allow major mechanistic discoveries, ushering genetic manipulations and preclinical assessment of therapies. Histology for lesion counting and morphometry is essential yet tedious and time consuming. We herein describe the application and validations of X-ray micro-computed tomography (micro-CT), a non-destructive technique allowing three-dimensional CCM lesion count and volumetric measurements, in transgenic murine brains. NEW
METHOD: We hereby describe a new contrast soaking technique not previously applied to murine models of CCM disease. Volumetric segmentation and image processing paradigm allowed for histologic correlations and quantitative validations not previously reported with the micro-CT technique in brain vascular disease.
RESULTS: Twenty-two hyper-dense areas on micro-CT images, identified as CCM lesions, were matched by histology. The inter-rater reliability analysis showed strong consistency in the CCM lesion identification and staging (K=0.89, p<0.0001) between the two techniques. Micro-CT revealed a 29% greater CCM lesion detection efficiency, and 80% improved time efficiency. COMPARISON WITH EXISTING
METHOD: Serial integrated lesional area by histology showed a strong positive correlation with micro-CT estimated volume (r(2)=0.84, p<0.0001).
CONCLUSIONS: Micro-CT allows high throughput assessment of lesion count and volume in pre-clinical murine models of CCM. This approach complements histology with improved accuracy and efficiency, and can be applied for lesion burden assessment in other brain diseases.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral cavernous malformation; Iodine contrast; Micro-CT; Morphometry

Mesh:

Substances:

Year:  2016        PMID: 27345427      PMCID: PMC5003657          DOI: 10.1016/j.jneumeth.2016.06.021

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  63 in total

1.  Contrast in complex images.

Authors:  E Peli
Journal:  J Opt Soc Am A       Date:  1990-10       Impact factor: 2.129

Review 2.  Cerebral microhemorrhage.

Authors:  Anand Viswanathan; Hugues Chabriat
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

Review 3.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

Authors:  Julius Sim; Chris C Wright
Journal:  Phys Ther       Date:  2005-03

4.  Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.

Authors:  Angeliki Louvi; Leiling Chen; Aimee M Two; Haifeng Zhang; Wang Min; Murat Günel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

5.  A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.

Authors:  David A McDonald; Robert Shenkar; Changbin Shi; Rebecca A Stockton; Amy L Akers; Melanie H Kucherlapati; Raju Kucherlapati; James Brainer; Mark H Ginsberg; Issam A Awad; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2010-10-11       Impact factor: 6.150

6.  Cavernous malformations and hemorrhage risk.

Authors:  Douglas Kondziolka; Edward A Monaco; L Dade Lunsford
Journal:  Prog Neurol Surg       Date:  2012-12-11

7.  Contrast-Enhanced Nanofocus X-Ray Computed Tomography Allows Virtual Three-Dimensional Histopathology and Morphometric Analysis of Osteoarthritis in Small Animal Models.

Authors:  Greet Kerckhofs; Julie Sainz; Marina Maréchal; Martine Wevers; Tom Van de Putte; Liesbet Geris; Jan Schrooten
Journal:  Cartilage       Date:  2014-01       Impact factor: 4.634

8.  An investigation of the efficacy and mechanism of contrast-enhanced X-ray computed tomography utilizing iodine for large specimens through experimental and simulation approaches.

Authors:  Zhiheng Li; Julia A Clarke; Richard A Ketcham; Matthew W Colbert; Fei Yan
Journal:  BMC Physiol       Date:  2015-12-21

9.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

Review 10.  Diffusible iodine-based contrast-enhanced computed tomography (diceCT): an emerging tool for rapid, high-resolution, 3-D imaging of metazoan soft tissues.

Authors:  Paul M Gignac; Nathan J Kley; Julia A Clarke; Matthew W Colbert; Ashley C Morhardt; Donald Cerio; Ian N Cost; Philip G Cox; Juan D Daza; Catherine M Early; M Scott Echols; R Mark Henkelman; A Nele Herdina; Casey M Holliday; Zhiheng Li; Kristin Mahlow; Samer Merchant; Johannes Müller; Courtney P Orsbon; Daniel J Paluh; Monte L Thies; Henry P Tsai; Lawrence M Witmer
Journal:  J Anat       Date:  2016-03-11       Impact factor: 2.610

View more
  13 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease.

Authors:  Lisa McKerracher; Robert Shenkar; Matthew Abbinanti; Ying Cao; Amy Peiper; James K Liao; Rhonda Lightle; Thomas Moore; Nicholas Hobson; Carol Gallione; Joerg Ruschel; Janne Koskimäki; Romuald Girard; Kenneth Rosen; Douglas A Marchuk; Issam A Awad
Journal:  Transl Stroke Res       Date:  2019-08-24       Impact factor: 6.829

3.  Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.

Authors:  Alan T Tang; Katie R Sullivan; Courtney C Hong; Lauren M Goddard; Aparna Mahadevan; Aileen Ren; Heidy Pardo; Amy Peiper; Erin Griffin; Ceylan Tanes; Lisa M Mattei; Jisheng Yang; Li Li; Patricia Mericko-Ishizuka; Le Shen; Nicholas Hobson; Romuald Girard; Rhonda Lightle; Thomas Moore; Robert Shenkar; Sean P Polster; Claudia J Roedel; Ning Li; Qin Zhu; Kevin J Whitehead; Xiangjian Zheng; Amy Akers; Leslie Morrison; Helen Kim; Kyle Bittinger; Christopher J Lengner; Markus Schwaninger; Anna Velcich; Leonard Augenlicht; Salim Abdelilah-Seyfried; Wang Min; Douglas A Marchuk; Issam A Awad; Mark L Kahn
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

4.  RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.

Authors:  Robert Shenkar; Changbin Shi; Cecilia Austin; Thomas Moore; Rhonda Lightle; Ying Cao; Lingjiao Zhang; Meijing Wu; Hussein A Zeineddine; Romuald Girard; David A McDonald; Autumn Rorrer; Carol Gallione; Peter Pytel; James K Liao; Douglas A Marchuk; Issam A Awad
Journal:  Stroke       Date:  2016-11-22       Impact factor: 7.914

5.  High-resolution micro-CT for 3D infarct characterization and segmentation in mice stroke models.

Authors:  Raquel Pinto; Jan Matula; Andrea Lobo; Maria Gomez-Lazaro; Mafalda Sousa; Tomas Zikmund; Jozef Kaiser; João R Gomes
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

6.  NIR-II window tracking of hyperglycemia induced intracerebral hemorrhage in cerebral cavernous malformation deficient mice.

Authors:  Abdul K Parchur; Zhi Fang; Jaidip M Jagtap; Gayatri Sharma; Christopher Hansen; Shayan Shafiee; Wenquan Hu; Qing R Miao; Amit Joshi
Journal:  Biomater Sci       Date:  2020-08-21       Impact factor: 7.590

Review 7.  Brain Vascular Imaging Techniques.

Authors:  Bàrbara Laviña
Journal:  Int J Mol Sci       Date:  2016-12-30       Impact factor: 5.923

8.  Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.

Authors:  Alan T Tang; Jaesung P Choi; Jonathan J Kotzin; Yiqing Yang; Courtney C Hong; Nicholas Hobson; Romuald Girard; Hussein A Zeineddine; Rhonda Lightle; Thomas Moore; Ying Cao; Robert Shenkar; Mei Chen; Patricia Mericko; Jisheng Yang; Li Li; Ceylan Tanes; Dmytro Kobuley; Urmo Võsa; Kevin J Whitehead; Dean Y Li; Lude Franke; Blaine Hart; Markus Schwaninger; Jorge Henao-Mejia; Leslie Morrison; Helen Kim; Issam A Awad; Xiangjian Zheng; Mark L Kahn
Journal:  Nature       Date:  2017-05-10       Impact factor: 49.962

Review 9.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

10.  Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.

Authors:  Miguel Alejandro Lopez-Ramirez; Catherine Chinhchu Lai; Shady Ibrahim Soliman; Preston Hale; Angela Pham; Esau J Estrada; Sara McCurdy; Romuald Girard; Riya Verma; Thomas Moore; Rhonda Lightle; Nicholas Hobson; Robert Shenkar; Orit Poulsen; Gabriel G Haddad; Richard Daneman; Brendan Gongol; Hao Sun; Frederic Lagarrigue; Issam A Awad; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.